These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 11580218

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
    Barkoff AM, Guiso N, Guillot S, Xing D, Markey K, Berbers G, Mertsola J, He Q.
    J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
    Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G.
    Scand J Infect Dis; 1995 Jun; 27(3):273-7. PubMed ID: 8539553
    [Abstract] [Full Text] [Related]

  • 10. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD, Gornbein J, Heininger U, Stehr K.
    Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
    Storsaeter J, Hallander HO, Gustafsson L, Olin P.
    Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
    [Abstract] [Full Text] [Related]

  • 13. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D, Maes A, Behr-Gross ME, Costanzo A, Daas A, Buchheit KH.
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of chemically cross-linked antigens for acellular pertussis vaccine.
    Watanabe M, Nagai M, Funaishi K, Endoh M.
    Vaccine; 2000 Dec 08; 19(9-10):1199-203. PubMed ID: 11137257
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.
    Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
    Podda A, Carapella De Luca E, Titone L, Casadei AM, Cascio A, Bartalini M, Volpini G, Peppoloni S, Marsili I, Nencioni L.
    J Pediatr; 1993 Jul 22; 123(1):81-4. PubMed ID: 8320630
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
    He Q, Tran Minh NN, Edelman K, Viljanen MK, Arvilommi H, Mertsola J.
    Infect Immun; 1998 Aug 22; 66(8):3796-801. PubMed ID: 9673264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.